US4900303A
(en)
*
|
1978-03-10 |
1990-02-13 |
Lemelson Jerome H |
Dispensing catheter and method
|
US4291015A
(en)
*
|
1979-08-14 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing a vasodilator
|
JPS5668609A
(en)
*
|
1979-11-07 |
1981-06-09 |
Nippon Kayaku Co Ltd |
Phthalazinol preparation
|
CA1163195A
(fr)
*
|
1980-06-26 |
1984-03-06 |
Alec D. Keith |
Milieu de diffusion polymerique contenant un vasodilatateur
|
JPS5758615A
(en)
*
|
1980-09-26 |
1982-04-08 |
Nippon Soda Co Ltd |
Film agnent and its preparation
|
US4357935A
(en)
*
|
1980-11-12 |
1982-11-09 |
C. R. Canfield & Company, Inc. |
Dry method of making a dry socket dressing
|
JPS57110254A
(en)
*
|
1980-12-29 |
1982-07-09 |
Teijin Ltd |
Coating agent of injured membrane part of oral cavity
|
AU550098B2
(en)
*
|
1981-05-02 |
1986-03-06 |
Smith & Nephew Associated Companies Plc |
Sterile dressing
|
CA1218604A
(fr)
*
|
1981-07-08 |
1987-03-03 |
Alec D. Keith |
Vehicules de trinitroglycerol a decharge temporisee, et leurs domaines d'emploi
|
SU1011126A1
(ru)
*
|
1981-07-14 |
1983-04-15 |
Всесоюзный научно-исследовательский и испытательный институт медицинской техники |
Средство дл лечени сахарного диабета
|
GB2105990B
(en)
*
|
1981-08-27 |
1985-06-19 |
Nitto Electric Ind Co |
Adhesive skin patches
|
CH653550A5
(de)
*
|
1981-10-20 |
1986-01-15 |
Sandoz Ag |
Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
|
US4369172A
(en)
*
|
1981-12-18 |
1983-01-18 |
Forest Laboratories Inc. |
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
|
JPS58109059A
(ja)
*
|
1981-12-23 |
1983-06-29 |
帝人株式会社 |
口内炎治療用被覆剤
|
US4482533A
(en)
*
|
1982-01-11 |
1984-11-13 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing propranolol
|
JPS58128314A
(ja)
*
|
1982-01-26 |
1983-07-30 |
Nitto Electric Ind Co Ltd |
粘膜製剤
|
US4389393A
(en)
*
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
JPS58174307A
(ja)
*
|
1982-04-06 |
1983-10-13 |
Teikoku Seiyaku Kk |
可食性口腔内貼付薬
|
US4659696A
(en)
*
|
1982-04-30 |
1987-04-21 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition and its nasal or vaginal use
|
JPS58213709A
(ja)
*
|
1982-06-05 |
1983-12-12 |
Teikoku Seiyaku Kk |
歯肉粘膜用貼付剤
|
JPS5948409A
(ja)
*
|
1982-09-10 |
1984-03-19 |
Teikoku Seiyaku Kk |
矯正的歯牙移動促進剤
|
JPS5967218A
(ja)
*
|
1982-10-07 |
1984-04-16 |
Grelan Pharmaceut Co Ltd |
軟質な口腔製剤
|
JPS59122422A
(ja)
*
|
1982-12-29 |
1984-07-14 |
Toko Yakuhin Kogyo Kk |
口腔用消炎鎮痛ゲル剤
|
JPS59186913A
(ja)
*
|
1983-04-08 |
1984-10-23 |
Teikoku Seiyaku Kk |
口腔粘膜貼付用基剤
|
US4605548A
(en)
*
|
1983-05-31 |
1986-08-12 |
Nitto Electric Industrial Co., Ltd. |
Drug administration material
|
JPS59222406A
(ja)
*
|
1983-06-01 |
1984-12-14 |
Teijin Ltd |
歯周疾患治療用製剤及びその製造法
|
US4892736A
(en)
*
|
1983-10-07 |
1990-01-09 |
The Forsyth Dental Infirmary For Children |
Intra-pocket drug delivery devices for treatment of periodontal diseases
|
US4563184A
(en)
*
|
1983-10-17 |
1986-01-07 |
Bernard Korol |
Synthetic resin wound dressing and method of treatment using same
|
EP0501523B1
(fr)
*
|
1983-11-14 |
1997-04-09 |
Columbia Laboratories, Inc. |
Compositions bioadhésives
|
US4983392A
(en)
*
|
1983-11-14 |
1991-01-08 |
Bio-Mimetics, Inc. |
Bioadhesive compositions and methods of treatment therewith
|
US4795436A
(en)
*
|
1983-11-14 |
1989-01-03 |
Bio-Mimetics, Inc. |
Bioadhesive composition and method of treatment therewith
|
US4680323A
(en)
*
|
1983-12-01 |
1987-07-14 |
Hans Lowey |
Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
|
DE3580384D1
(de)
*
|
1984-04-09 |
1990-12-13 |
Toyo Boseki |
Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
|
US4863737A
(en)
*
|
1985-05-01 |
1989-09-05 |
University Of Utah |
Compositions and methods of manufacture of compressed powder medicaments
|
US5855908A
(en)
*
|
1984-05-01 |
1999-01-05 |
University Of Utah Research Foundation |
Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
|
US4597961A
(en)
*
|
1985-01-23 |
1986-07-01 |
Etscorn Frank T |
Transcutaneous application of nicotine
|
US4568536A
(en)
*
|
1985-02-08 |
1986-02-04 |
Ethicon, Inc. |
Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
|
JPS61240963A
(ja)
*
|
1985-04-18 |
1986-10-27 |
ユニチカ株式会社 |
創傷被覆保護材
|
US5122127A
(en)
*
|
1985-05-01 |
1992-06-16 |
University Of Utah |
Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
|
US4885173A
(en)
*
|
1985-05-01 |
1989-12-05 |
University Of Utah |
Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
|
US5132114A
(en)
*
|
1985-05-01 |
1992-07-21 |
University Of Utah Research Foundation |
Compositions and methods of manufacture of compressed powder medicaments
|
US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
EP0205336B1
(fr)
*
|
1985-06-11 |
1991-09-11 |
Teijin Limited |
Préparation pharmaceutique orale à effet entretenn
|
GB8514665D0
(en)
*
|
1985-06-11 |
1985-07-10 |
Eroceltique Sa |
Oral pharmaceutical composition
|
US4616644A
(en)
*
|
1985-06-14 |
1986-10-14 |
Johnson & Johnson Products, Inc. |
Hemostatic adhesive bandage
|
EP0244405B1
(fr)
*
|
1985-10-31 |
1991-10-23 |
Kv Pharmaceutical Company |
Systemes de liberation d'agents actifs dans le vagin
|
US4712460A
(en)
*
|
1985-11-18 |
1987-12-15 |
Biotrack, Inc. |
Integrated drug dosage form and metering system
|
EP0223245A3
(fr)
*
|
1985-11-21 |
1989-05-10 |
Mitsui Petrochemical Industries, Ltd. |
Compositions pouvant être durcies à libération prolongée pour agents actifs dentaires
|
JPH07553B2
(ja)
*
|
1985-12-09 |
1995-01-11 |
佐藤製薬株式会社 |
フイルム状製剤
|
US4755386A
(en)
*
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
DE3601923A1
(de)
*
|
1986-01-23 |
1987-07-30 |
Behringwerke Ag |
Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
AU592629B2
(en)
*
|
1986-01-31 |
1990-01-18 |
Whitby Research, Inc. |
Compositions comprising 1-substituted azacycloalkanes and their uses
|
US4764378A
(en)
*
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
US4875473A
(en)
*
|
1986-04-03 |
1989-10-24 |
Bioderm, Inc. |
Multi-layer wound dressing having oxygen permeable and oxygen impermeable layers
|
DE3775830D1
(de)
*
|
1986-06-13 |
1992-02-20 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
US4713243A
(en)
*
|
1986-06-16 |
1987-12-15 |
Johnson & Johnson Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
USRE33093E
(en)
*
|
1986-06-16 |
1989-10-17 |
Johnson & Johnson Consumer Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
US4869908A
(en)
*
|
1987-01-09 |
1989-09-26 |
K.V. Pharmaceutical Co. |
Fibre formulations
|
ES2061623T3
(es)
*
|
1987-03-02 |
1994-12-16 |
Brocades Pharma Bv |
Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US4915948A
(en)
*
|
1987-08-31 |
1990-04-10 |
Warner-Lambert Company |
Tablets having improved bioadhesion to mucous membranes
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
FR2621483B1
(fr)
*
|
1987-10-08 |
1991-09-20 |
Medibrevex |
Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
|
US4978391A
(en)
*
|
1987-11-13 |
1990-12-18 |
Dentsply Management Corp. |
Intraoral medicament delivery and procedure
|
US5211958A
(en)
*
|
1987-11-30 |
1993-05-18 |
Gist-Brocades, N.V. |
Pharmaceutical composition and process for its preparation
|
DE68916983T2
(de)
*
|
1988-02-25 |
1995-01-19 |
Yamanouchi Europ Bv |
Verfahren zur Herstellung eines pharmazeutischen Granulats.
|
US5064650A
(en)
*
|
1988-04-19 |
1991-11-12 |
Southwest Research Institute |
Controlled-release salt sensitive capsule for oral use and adhesive system
|
US5081157A
(en)
*
|
1988-05-02 |
1992-01-14 |
Zila Pharmaceuticals, Inc. |
Compositions and in situ methods for forming films on body tissue
|
US5081158A
(en)
*
|
1988-05-02 |
1992-01-14 |
Zila Pharmaceuticals, Inc. |
Compositions and in situ methods for forming films on body tissue
|
WO1990001969A1
(fr)
*
|
1988-08-24 |
1990-03-08 |
Slepian Marvin J |
Etancheification a l'aide d'un polymere biodegradable de la surface interieure d'une lumiere d'un organe
|
US5749915A
(en)
*
|
1988-08-24 |
1998-05-12 |
Focal, Inc. |
Polymeric endoluminal paving process
|
US5073374A
(en)
*
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
US5112616A
(en)
*
|
1988-11-30 |
1992-05-12 |
Schering Corporation |
Fast dissolving buccal tablet
|
PH26730A
(en)
*
|
1988-12-30 |
1992-09-28 |
Ciba Geigy Ag |
Coated adhesive tablets
|
JP2656338B2
(ja)
*
|
1989-01-31 |
1997-09-24 |
日東電工株式会社 |
口腔粘膜貼付製剤
|
DE69003632T2
(de)
|
1989-02-28 |
1994-02-17 |
Teijin Ltd |
Pflaster sowie dessen herstellung.
|
US5336210A
(en)
*
|
1989-02-28 |
1994-08-09 |
Teijin Limited |
Plaster agent
|
US5139023A
(en)
*
|
1989-06-02 |
1992-08-18 |
Theratech Inc. |
Apparatus and method for noninvasive blood glucose monitoring
|
US5750136A
(en)
*
|
1989-11-03 |
1998-05-12 |
Riker Laboratories, Inc. |
Bioadhesive composition and patch
|
US5750134A
(en)
*
|
1989-11-03 |
1998-05-12 |
Riker Laboratories, Inc. |
Bioadhesive composition and patch
|
US5284659A
(en)
*
|
1990-03-30 |
1994-02-08 |
Cherukuri Subraman R |
Encapsulated flavor with bioadhesive character in pressed mints and confections
|
EP0451433B1
(fr)
*
|
1990-04-12 |
1996-10-23 |
Janssen Pharmaceutica N.V. |
Composition d'un support bioadhésif pour la libération soutenue d'un principe actif
|
US5039526A
(en)
*
|
1990-04-16 |
1991-08-13 |
Colgate-Palmolive Company |
Buccal lozenge for fluoride ion medication
|
US5059123A
(en)
*
|
1990-05-14 |
1991-10-22 |
Jernberg Gary R |
Periodontal barrier and method for aiding periodontal tissue regeneration
|
US5290271A
(en)
*
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
US5197882A
(en)
*
|
1990-05-14 |
1993-03-30 |
Gary R. Jernberg |
Periodontal barrier and method for aiding periodontal tissue regeneration agents
|
WO1991017745A1
(fr)
*
|
1990-05-23 |
1991-11-28 |
Southwest Research Institute |
Systeme a filament d'acheminement d'un medicament et procede
|
IT1251114B
(it)
*
|
1991-07-26 |
1995-05-04 |
Farcon Ag |
Forme farmaceutiche antivirali per applicazione vaginale
|
US5192802A
(en)
*
|
1991-09-25 |
1993-03-09 |
Mcneil-Ppc, Inc. |
Bioadhesive pharmaceutical carrier
|
US5364634A
(en)
*
|
1991-11-08 |
1994-11-15 |
Southwest Research Institute |
Controlled-release PH sensitive capsule and adhesive system and method
|
WO1993014158A1
(fr)
*
|
1992-01-17 |
1993-07-22 |
Berwind Pharmaceutical Services, Inc. |
Revetement par pellicule et compositions pour revetement par pellicule a base de polymeres cellulosiques et de lactose
|
EP0641192B1
(fr)
*
|
1992-05-18 |
1997-07-23 |
Minnesota Mining And Manufacturing Company |
Dispositif d'apport de medicament a travers des muqueuses
|
CA2169729C
(fr)
*
|
1993-08-19 |
2001-04-03 |
James E. Biegajski |
Adhesif a simple pression, soluble dans l'eau
|
FR2712807B1
(fr)
*
|
1993-11-24 |
1996-02-23 |
Vetoquinol Sa |
Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
|
FR2718020B1
(fr)
*
|
1994-04-01 |
1996-05-31 |
Biotec Centre Sa |
Composition galénique mucoadhésive hétérofonctionnelle.
|
EP1051972B1
(fr)
*
|
1994-05-27 |
2007-10-03 |
Strakan International Limited |
Compositions de donneurs d'oxyde nitrique et méthode pour le traitement de troubles anaux
|
US5504117A
(en)
*
|
1994-05-27 |
1996-04-02 |
Neptune Pharmaceutical Corporation |
Pharmacologic preparation for the treatment of anal disorders
|
US5766620A
(en)
*
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
US5849322A
(en)
*
|
1995-10-23 |
1998-12-15 |
Theratech, Inc. |
Compositions and methods for buccal delivery of pharmaceutical agents
|
IT1275816B1
(it)
|
1995-10-27 |
1997-10-17 |
Montefarmaco Spa |
Composizioni farmaceutiche solide per uso vaginale
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US5648358A
(en)
*
|
1996-03-05 |
1997-07-15 |
Mitra; Sekhar |
Compositions and methods for treating respiratory disorders
|
US5955097A
(en)
*
|
1996-10-18 |
1999-09-21 |
Virotex Corporation |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
FR2762513B1
(fr)
*
|
1997-04-23 |
2003-08-22 |
Permatec Pharma Ag |
Comprimes bioadhesifs
|
US6096328A
(en)
*
|
1997-06-06 |
2000-08-01 |
The Procter & Gamble Company |
Delivery system for an oral care substance using a strip of material having low flexural stiffness
|
US6123957A
(en)
*
|
1997-07-16 |
2000-09-26 |
Jernberg; Gary R. |
Delivery of agents and method for regeneration of periodontal tissues
|
US5942244A
(en)
*
|
1997-07-31 |
1999-08-24 |
Farmo-Nat Ltd. |
Local oral herbal slow release tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
US6103266A
(en)
*
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US6432448B1
(en)
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
DE60002471T2
(de)
|
1999-07-02 |
2004-02-19 |
The Procter & Gamble Company, Cincinnati |
Zusammensetzungen zur freisetzung von mundpflegewirkstoffen enthaltend organosiloxan harze durch verwendung eines wiederablösbaren trägerstreifens
|
US6432415B1
(en)
|
1999-12-17 |
2002-08-13 |
Axrix Laboratories, Inc. |
Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
|
US20040047910A1
(en)
*
|
2000-07-07 |
2004-03-11 |
Christian Beckett |
Suppository and composition comprising at least one polyethylene glycol
|
WO2002007674A2
(fr)
*
|
2000-07-21 |
2002-01-31 |
Ceramoptec Industries, Inc. |
Amelioration de la penetration d'un compose dans et a travers des follicules pileux
|
US6648911B1
(en)
|
2000-11-20 |
2003-11-18 |
Avantec Vascular Corporation |
Method and device for the treatment of vulnerable tissue site
|
US6932861B2
(en)
|
2000-11-28 |
2005-08-23 |
Fmc Corporation |
Edible PGA coating composition
|
AU2002225763A1
(en)
|
2000-11-28 |
2002-06-11 |
Fmc Corporation |
Edible pga(propylene glycol alginate) coating composition
|
KR100685945B1
(ko)
|
2000-12-29 |
2007-02-23 |
엘지.필립스 엘시디 주식회사 |
액정표시장치 및 그 제조방법
|
US20060073174A1
(en)
*
|
2001-08-16 |
2006-04-06 |
Access Pharmaceuticals, Inc. |
Adherent and erodible film to treat a moist surface of a body tissue
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
US8765167B2
(en)
*
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US7357891B2
(en)
*
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US20060039958A1
(en)
*
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7425292B2
(en)
*
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US20050003048A1
(en)
*
|
2002-02-11 |
2005-01-06 |
Edizone, Lc |
Electrolyte-containing orally soluble films
|
US20040247746A1
(en)
*
|
2002-02-11 |
2004-12-09 |
Edizone, Lc |
Delivery units of thick orally soluble polymer
|
US20030167556A1
(en)
*
|
2002-03-05 |
2003-09-11 |
Consumers Choice Systems, Inc. |
Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US20030194420A1
(en)
*
|
2002-04-11 |
2003-10-16 |
Richard Holl |
Process for loading a drug delivery device
|
WO2003092468A2
(fr)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Systemes de fixation et de confinement structurels de matrices biologiques et procedes d'utilisation de ceux-ci
|
AU2003268015A1
(en)
*
|
2002-07-22 |
2004-02-09 |
Kosmos Pharma |
Packaging and dispensing of rapid dissolve dosage form
|
US8524200B2
(en)
|
2002-09-11 |
2013-09-03 |
The Procter & Gamble Company |
Tooth whitening products
|
DE10252726B4
(de)
|
2002-11-13 |
2008-05-08 |
Lts Lohmann Therapie-Systeme Ag |
Mehrschichtiges transmucosales therapeutisches System
|
US20040096569A1
(en)
*
|
2002-11-15 |
2004-05-20 |
Barkalow David G. |
Edible film products and methods of making same
|
US20040111275A1
(en)
*
|
2002-11-15 |
2004-06-10 |
Kroll David B. |
Methods for marketing and generating revenue from edible thin films
|
US20040156794A1
(en)
*
|
2003-02-11 |
2004-08-12 |
Barkalow David G. |
Bioerodible and bioadhesive confectionery products and methods of making same
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7306812B2
(en)
*
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US20040241294A1
(en)
*
|
2003-05-31 |
2004-12-02 |
Barabolak Roman M. |
Edible films including aspartame and methods of making same
|
US20050118261A1
(en)
*
|
2003-06-12 |
2005-06-02 |
Oien Hal J. |
Compositions and methods of administering doxepin to mucosal tissue
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
EP1660013A4
(fr)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
|
US8529939B2
(en)
*
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
EP1793799B1
(fr)
*
|
2004-08-02 |
2010-05-05 |
Glaxo Group Limited |
Nouvelle composition pour traiter la xerostomie
|
US20060057165A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
JP5969975B2
(ja)
*
|
2005-06-06 |
2016-08-17 |
株式会社明治 |
口腔ケア用組成物及び口腔ケア剤
|
JP5963383B2
(ja)
*
|
2005-06-06 |
2016-08-03 |
株式会社明治 |
口腔ケア用組成物
|
US20070026052A1
(en)
*
|
2005-07-28 |
2007-02-01 |
Baggett Richard W |
Hemostatic material
|
CA2949643C
(fr)
|
2005-09-27 |
2018-05-15 |
Tissuetech, Inc. |
Preparations de membrane amniotique et compositions purifiees, et procedes d'utilisation
|
US8187639B2
(en)
*
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
WO2007062266A2
(fr)
|
2005-11-28 |
2007-05-31 |
Marinus Pharmaceuticals |
Formes galeniques de ganaxolone et procedes de preparation et d'utilisation de celles-ci
|
RU2008124109A
(ru)
*
|
2005-12-08 |
2010-01-20 |
МДРНА, Инк. (US) |
Чресслизистая доставка стабилизированных композиций эксендина
|
FR2896057A1
(fr)
*
|
2006-01-12 |
2007-07-13 |
St Microelectronics Sa |
Procede et dispositif de generation d'un nombre aleatoire dans un peripherique usb
|
CA2636026A1
(fr)
*
|
2006-01-20 |
2007-07-26 |
Monosol Rx, Llc |
Emballages doubles d'un film et leur procede de fabrication
|
AU2007207503A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Monosol Rx, Llc |
Film bandage for mucosal administration of actives
|
US20070190013A1
(en)
*
|
2006-02-13 |
2007-08-16 |
Yeli Zhang |
Film and film-forming compositions
|
US8349120B2
(en)
*
|
2006-03-07 |
2013-01-08 |
Ora Health Corporation |
Multi-layer patch made on a sheet and enclosed in a blister
|
US20070248655A1
(en)
*
|
2006-04-21 |
2007-10-25 |
Haley Jeffrey T |
Lenticular shaped protective mouth sore discs
|
US20070293587A1
(en)
*
|
2006-05-23 |
2007-12-20 |
Haley Jeffrey T |
Combating sinus, throat, and blood infections with xylitol delivered in the mouth
|
EP2037895A4
(fr)
*
|
2006-05-23 |
2009-12-02 |
Orahealth Corp |
Trochisques à base de xilitol et leurs procédés d'utilisation
|
EP1872775A1
(fr)
*
|
2006-06-29 |
2008-01-02 |
Polichem S.A. |
Emploi d'une matrice hydrophile contenant un dérivé polyacrylique, un éther de cellulose et un désintégrant, pour la production d'un médicament pour le traitement des troubles génitales d'une femme
|
CN103550136B
(zh)
*
|
2006-07-21 |
2016-04-13 |
生物递送科学国际公司 |
吸收增强的经粘膜递送装置
|
ATE510538T1
(de)
|
2006-08-11 |
2011-06-15 |
Univ Johns Hopkins |
Zusammensetzungen und verfahren für nervenschutz
|
CN101516331A
(zh)
*
|
2006-09-20 |
2009-08-26 |
莫诺索尔克斯有限公司 |
含有抗泡沫调味剂的可食用水溶性膜
|
EP2532235A1
(fr)
|
2006-09-22 |
2012-12-12 |
Pharmacyclics, Inc. |
Inhibiteurs de la tyrosine kinase de bruton
|
CA2664615A1
(fr)
*
|
2006-09-29 |
2008-04-10 |
Monosol Rx, Llc |
Conditionnement dans lequel un film est incorpore et son procede de fabrication
|
KR20090091321A
(ko)
|
2006-11-28 |
2009-08-27 |
마리누스 파마슈티컬스 |
나노입자 제형, 이의 제조방법 및 이의 용도
|
WO2008116004A2
(fr)
|
2007-03-19 |
2008-09-25 |
Vita Sciences, Llc |
Timbre transdermique et méthode for d'administration de vitamine b12
|
US20080241795A1
(en)
*
|
2007-03-26 |
2008-10-02 |
Block James C |
Prevention and treatment of alveolar osteitis
|
US8263641B2
(en)
|
2007-09-10 |
2012-09-11 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20100285098A1
(en)
*
|
2007-09-11 |
2010-11-11 |
Haley Jeffrey T |
Adhering troches with santacid for treatment of throat esophagus and stomach
|
WO2009086483A2
(fr)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Particules de protéines biocompatibles, dispositifs à particules et leurs procédés
|
WO2009137631A2
(fr)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Procédés d'identification de composés ayant une incidence sur l'expression d'isoformes de protéines associées au cancer
|
EP2283160A4
(fr)
*
|
2008-05-07 |
2012-01-04 |
Wintherix Llc |
Procédés pour identifier des composés qui modulent la signalisation wnt dans des cellules cancéreuses
|
JP2011525536A
(ja)
*
|
2008-06-23 |
2011-09-22 |
バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド |
多方向性粘膜送達装置および使用法
|
TWI392673B
(zh)
|
2008-08-27 |
2013-04-11 |
Calcimedica Inc |
調控細胞內鈣離子濃度之化合物
|
US10016534B2
(en)
|
2008-11-17 |
2018-07-10 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
EP2419085A4
(fr)
*
|
2009-04-14 |
2013-04-24 |
Univ California |
Dispositifs améliorés pour médicaments à usage oral et formulations médicamenteuses
|
EP2421901B1
(fr)
|
2009-04-24 |
2015-10-28 |
Tissue Tech, Inc. |
Composition contenant le complexe hc ha et procédés d'utilisation de celle-ci
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US8701671B2
(en)
|
2011-02-04 |
2014-04-22 |
Joseph E. Kovarik |
Non-surgical method and system for reducing snoring
|
US9549842B2
(en)
|
2011-02-04 |
2017-01-24 |
Joseph E. Kovarik |
Buccal bioadhesive strip and method of treating snoring and sleep apnea
|
WO2011064316A2
(fr)
|
2009-11-25 |
2011-06-03 |
Paolo Botti |
Administration de peptides par voie muqueuse
|
WO2011097594A2
(fr)
|
2010-02-08 |
2011-08-11 |
Kinagen, Inc. |
Methodes therapeutiques et compositions impliquant l'inhibition de la kinase allosterique
|
MX339192B
(es)
|
2010-03-24 |
2016-05-13 |
Amitech Therapeutic Solutions Inc |
Compuestos heterociclicos utiles para inhibicion de cinasa.
|
WO2011130455A1
(fr)
|
2010-04-13 |
2011-10-20 |
Najib Babul |
Compositions pharmaceutiques dermiques de 1-méthyl-2',6'-pipécoloxylidide et méthode d'utilisation
|
EP2558866B1
(fr)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentialisation de l'activité anticancéreuse par polythérapie avec des inhibiteurs de la voie ber
|
DK2563776T3
(en)
|
2010-04-27 |
2016-09-19 |
Calcimedica Inc |
Relations that modulate intracellular calcium
|
AU2011248579A1
(en)
|
2010-04-27 |
2012-11-29 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20130259875A1
(en)
|
2010-05-11 |
2013-10-03 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of amyotrophic lateral sclerosis
|
MX2020004501A
(es)
|
2010-06-03 |
2021-11-09 |
Pharmacyclics Llc |
El uso de inhibidores de la tirosina quinasa de bruton (btk).
|
JP5819949B2
(ja)
|
2010-06-10 |
2015-11-24 |
ミダテック リミテッド |
ナノ粒子フィルム送達システム
|
JP5916149B2
(ja)
|
2010-08-27 |
2016-05-11 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
WO2012094360A2
(fr)
|
2011-01-04 |
2012-07-12 |
Gordon Chiu |
Agents biothérapeutiques pour le traitement des maladies infectieuses
|
EP2661264B1
(fr)
|
2011-01-07 |
2018-12-05 |
Allergan, Inc. |
Compositions de modification de mélanine et procédés d'utilisation
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
RU2013151164A
(ru)
|
2011-04-19 |
2015-05-27 |
Армс Фармасьютикал Ллк. |
Способ ингибирования вредных микроорганизмов и формирующая барьер композиция для этого способа
|
US10426761B2
(en)
|
2011-04-19 |
2019-10-01 |
Arms Pharmaceutical, Llc |
Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
|
WO2012149486A1
(fr)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Procédés de modulation de remodélisation osseuse
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
ES2660116T3
(es)
|
2011-08-18 |
2018-03-20 |
Biodelivery Sciences International, Inc. |
Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina
|
CA2795586A1
(fr)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methodes et compositions pour le traitement, la modification et la gestion de la douleur attribuable au cancer des os
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
US20130172424A1
(en)
|
2011-12-30 |
2013-07-04 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
FR2987264A1
(fr)
|
2012-02-23 |
2013-08-30 |
Golden Biotechnology Corp |
Methodes et compositions pour le traitement des metastases cancereuses
|
MX2014011473A
(es)
|
2012-03-26 |
2014-12-08 |
Golden Biotechnology Corp |
Procedimientos y composiciones de tratamiento de enfermedades vasculares arterioscleroticas.
|
US9456916B2
(en)
|
2013-03-12 |
2016-10-04 |
Medibotics Llc |
Device for selectively reducing absorption of unhealthy food
|
JP2015528001A
(ja)
|
2012-07-11 |
2015-09-24 |
ティッシュテック,インク. |
Hc−ha/ptx3複合体を含む組成物およびその使用方法
|
WO2014059333A1
(fr)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Composés qui modulent le calcium intracellulaire
|
PL2908798T3
(pl)
|
2012-10-17 |
2019-02-28 |
Procter & Gamble |
Pasek do wprowadzania środka aktywującego higienę jamy ustnej i sposoby stosowania środków aktywujących higienę jamy ustnej
|
US11446364B2
(en)
|
2012-11-14 |
2022-09-20 |
Smith & Nephew, Inc. |
Stable thermolysin hydrogel
|
CA2892084C
(fr)
|
2012-11-21 |
2020-11-10 |
Golden Biotechnology Corporation |
Methodes et compositions pour le traitement de maladies neurodegeneratives
|
TWI597061B
(zh)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
治療白血病之方法及組成物
|
US9011365B2
(en)
|
2013-03-12 |
2015-04-21 |
Medibotics Llc |
Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
|
US9067070B2
(en)
|
2013-03-12 |
2015-06-30 |
Medibotics Llc |
Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
|
US10232018B2
(en)
|
2013-03-14 |
2019-03-19 |
Mallinckrodt Ard Ip Limited |
ACTH for treatment of acute respiratory distress syndrome
|
US11452698B2
(en)
|
2013-03-15 |
2022-09-27 |
Smith & Nephew, Inc. |
Dissolvable gel-forming film for delivery of active agents
|
ES2764462T3
(es)
|
2013-03-15 |
2020-06-03 |
Braintree Laboratories Inc |
Comprimidos de composición farmacéutica oral de uso dual de sales de sulfato y métodos de uso de los mismos
|
US20160106813A1
(en)
|
2013-03-29 |
2016-04-21 |
Centre National De La Recherche Schientifique (Cnrs) |
Cgrp receptor agonist for hiv treatment or prevention
|
JP5775970B2
(ja)
*
|
2013-05-31 |
2015-09-09 |
久光製薬株式会社 |
口腔貼付剤
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
EP3077388A1
(fr)
|
2013-12-05 |
2016-10-12 |
Pharmacyclics, LLC |
Inhibiteurs de la tyrosine kinase de bruton
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
EP2889030A1
(fr)
|
2013-12-30 |
2015-07-01 |
Uluru Inc. |
Contrôler les taux d'érosion de dispositifs muco-adhésifs qui fournissent des actifs et d'autres composés et fournir des niveaux sanguins thérapeutiques variables et accrus
|
AU2015213681B2
(en)
|
2014-02-10 |
2020-03-12 |
Respivant Sciences Gmbh |
Mast cell stabilizers for lung disease treatment
|
US9962363B2
(en)
|
2014-02-10 |
2018-05-08 |
Patara Pharma, LLC |
Mast cell stabilizers treatment for systemic disorders
|
WO2015164213A1
(fr)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
Réaction de ligature bio-orthogonale rapide et efficace et hétérocycles contenant du bore utiles en association avec celle-ci
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
US20160243288A1
(en)
|
2015-02-23 |
2016-08-25 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
MX2017011018A
(es)
|
2015-02-27 |
2018-01-18 |
Curtana Pharmaceuticals Inc |
Inhibicion de la actividad de olig2.
|
US10342831B2
(en)
|
2015-05-20 |
2019-07-09 |
Tissuetech, Inc. |
Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
WO2017027402A1
(fr)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Méthodes de traitement de troubles systémiques aptes à être traités par des stabilisateurs de mastocytes, y compris de troubles liés aux mastocytes
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
WO2017040617A1
(fr)
|
2015-08-31 |
2017-03-09 |
Pharmacyclics Llc |
Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
WO2017147146A1
(fr)
|
2016-02-23 |
2017-08-31 |
Concentric Analgesics, Inc. |
Promédicaments d'agonistes du trpv1 phénolique
|
JP2019519487A
(ja)
|
2016-05-05 |
2019-07-11 |
アクエスティブ セラピューティクス インコーポレイテッド |
送達増強エピネフリン組成物
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
CA3024556A1
(fr)
|
2016-05-12 |
2017-11-16 |
The Regents Of The University Of Michigan |
Inhibiteurs de ash1l et methodes de traitement au moyen de ceux-ci
|
EP3463576A4
(fr)
|
2016-05-25 |
2020-01-15 |
Concentric Analgesics, Inc. |
Promédicaments à base d'agonistes de trpv1 phénoliques en association avec des anesthésiques locaux et des vasoconstricteurs pour améliorer une anesthésie locale
|
WO2017205769A1
(fr)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibiteurs de la kinase associée au récepteur de l'interleukine 1
|
WO2017205766A1
(fr)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibiteurs de la kinase associée au récepteur de l'interleukine-1
|
WO2017205762A1
(fr)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibiteurs de la kinase associée au récepteur de l'interleukine 1
|
JP7028860B2
(ja)
|
2016-08-26 |
2022-03-02 |
カーテナ ファーマシューティカルズ,インク. |
Olig2活性の阻害
|
JP2019528320A
(ja)
|
2016-08-31 |
2019-10-10 |
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングRespivant Sciences Gmbh |
特発性肺線維症による慢性咳の治療のためのクロモリン組成物
|
WO2018067341A1
(fr)
|
2016-10-07 |
2018-04-12 |
Patara Pharma, LLC |
Compositions à base de cromolyne pour le traitement d'une fibrose pulmonaire
|
JP7424637B2
(ja)
|
2017-11-10 |
2024-01-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ash1l分解剤及びそれを用いた治療方法
|
US11324729B2
(en)
|
2017-12-07 |
2022-05-10 |
The Regents Of The University Of Michigan |
NSD family inhibitors and methods of treatment therewith
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
CN112533581B
(zh)
|
2018-06-07 |
2024-08-30 |
密歇根大学董事会 |
Prc1抑制剂及用其进行治疗的方法
|
US10717712B2
(en)
|
2018-07-27 |
2020-07-21 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic TRPV1 agonists
|
JP7277087B2
(ja)
*
|
2018-08-17 |
2023-05-18 |
株式会社ダイセル |
包装体、錠剤入り包装体、包装体の収容部材の製造方法、及び包装体の収容部材の製造装置
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
AU2020240015A1
(en)
|
2019-03-15 |
2021-10-07 |
Unicycive Therapeutics Inc. |
Nicorandil derivatives
|
WO2022010537A1
(fr)
|
2020-07-10 |
2022-01-13 |
The Regents Of The University Of Michigan |
Inhibiteurs de gas41 et leurs méthodes d'utilisation
|
CA3202151A1
(fr)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Composes de pyrimidine fusionnee utilises comme inhibiteurs de l'interaction menine-mll
|
JP2024531170A
(ja)
|
2021-08-11 |
2024-08-29 |
バイオメア フュージョン,インコーポレイテッド |
真性糖尿病に対するメニン-mll相互作用の共有結合性阻害剤
|
WO2023027966A1
(fr)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Composés de pyrazine en tant qu'inhibiteurs irréversibles de flt3
|
WO2023039240A1
(fr)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
Inhibitors irréversibles de kras
|
WO2023086341A1
(fr)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibiteurs de kras
|
WO2023119230A1
(fr)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation
|
US11945785B2
(en)
|
2021-12-30 |
2024-04-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of FLT3
|
WO2023235618A1
(fr)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Composés de pyrimidine fusionnés en tant qu'inhibiteurs de la ménine
|